Diabetes Mellitus, Type 1: all 3,614 studies
Page 26 of 37. Open to participants first (586), then studies with results posted, then the rest; newest registration first within each.
- D-chiro-Inositol in Overweight Type 1 Diabetes PatientsCompletedNCT02730949Phase 3
- Closing the Loop in Adults With Type 1 Diabetes and HbA1C<7.5% Under Free Living ConditionsCompletedNCT02727231Not applicable
- Incretin Axis in Type 1 Diabetes MellitusStatus unknownNCT02725502Not applicable
- Single-dose Study to Evaluate Safety, Tolerability, and Pharmacodynamics of REMD-477 in Subjects With Type 1 Diabetes MellitusCompletedNCT02715193Phase 1
- Pharmacologic Response and Safety of Inhaled Insulin in Type 1 DiabetesCompletedNCT02713841Phase 1/2
- At Home Study of a Zone-Model Predictive Control (MPC) Controller and a Health Monitoring System (HMS) With the Diabetes Assistant (DiAs) System and Run-to-Run AdaptationCompletedNCT02705053Phase 3
- Bone and Vascular Health in Postmenopausal Women With Type 1 DiabetesCompletedNCT02693964
- Blood Glucose Variability and Insulin Action During Menstrual Cycle in Females With Type 1 DiabetesCompletedNCT02693938Not applicable
- Feasibility Study to Evaluate the Hybrid-Logic Closed Loop System in Type 1 DiabetesWithdrawnNCT02692547Not applicable
- Pediatric Type 1 Diabetes and RetinopathyCompletedNCT02691312
- Relation of Visceral Fat and Associated Cytokines With Early Cardiovascular Complications in Type 1 Diabetes.Status unknownNCT02689570
- 11C-5-HTP PET in Clinical Islet TransplantationCompletedNCT02689479Not applicable
- Evaluation of Extended Infusion Set Wear Using Medtronic Extended Wear Sof-set Infusion SetCompletedNCT02687256Phase 1
- Insulin Requirement for Pure-protein Meal in Children With Type 1 Diabetes on Insulin Pumps.Status unknownNCT02685449Phase 4
- T1 Diabetes Hypoglycemia Prevention PilotTerminatedNCT02682940Not applicable
- Evaluation of a Flash Glucose Monitoring System in Ambulatory Patients With Type 1 DiabetesCompletedNCT02677454Not applicable
- Impact of Food Carbohydrate and Insulin Dose Computing by on Smart Phone on Glucose Control in Patients With DiabetesCompletedNCT02676609Not applicable
- Physical Activity and Glycemic Control in AdolescentsCompletedNCT02674828Not applicable
- Comparison of Two Protocols on the Implementation of a Fasting Day in Type 1 DiabetesStatus unknownNCT02667769Not applicable
- Insulin-Glucose-Glucagon Network: Defining a Type 1 Diabetes Progression IndexCompletedNCT02663661Not applicable
- BD FlowSmart™ Subcutaneous Insulin Infusion Set User Preference and Claims StudyCompletedNCT02662842
- Investigating the Effectiveness of Tresiba® (Insulin Degludec) After Switching Basal Insulin in a Population With Type 1 or Type 2 Diabetes MellitusCompletedNCT02662114
- Study of Insulin Pump in Prevention of Low Glucose Events in Adults With Type 1 Diabetes at Risk of Severe HypoglycemiaCompletedNCT02657213Not applicable
- Prevention of Hypoglycemia After Exercise Using Closed Loop System in Children and Adolescents With Type 1 DiabetesCompletedNCT02657083Not applicable
- Feasibility Study to Evaluate the Hybrid-Logic Closed Loop System in Type 1 Diabetes The DREAMED TrailCompletedNCT02651181Not applicable
- A Performance Evaluation of the Enlite 3 SensorWithdrawnNCT02649010Not applicable
- A Feasibility Study to Evaluate the Performance of the Harmony 1 Sensors in Adults and PediatricsWithdrawnNCT02646878Not applicable
- Transplantation of Autologous Stem Cells for the Treatment of Type 1 Diabetes MellitusCompletedNCT02644759Phase 1/2
- The Effect of Melatonin on Early Signs of Hypertension in Teenagers With Diabetes Mellitus Type 1Status unknownNCT02644590Early Phase 1
- Motivational Interview in Adolescents With Poorly Controlled Type 1 DiabetesStatus unknownNCT02637154Not applicable
- Use of an Automated Insulin Delivery System Compared to Sensor Augmented Pump at Patients With Type 1 Diabetes (T1D)CompletedNCT02636491Not applicable
- A Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of a Single Dose of SAR438544 in Comparison to Glucagon in Type 1 Diabetes Mellitus Patients Under Induced HypoglycemiaWithdrawnNCT02635243Phase 1
- Effects of Capros in Patients With Type-1 DiabetesCompletedNCT02634216Not applicable
- Young With Diabetes Type 1 - Test of an mHealth AppCompletedNCT02632383Not applicable
- Impact of a Diabetes Camp on Glycemic Control Among Children and Adolescents Living With Type 1 Diabetes in CameroonCompletedNCT02632032Not applicable
- Insulin-based Strategies to Prevent Hypoglycemia During ExerciseCompletedNCT02631265Not applicable
- Studies on the Adaptive Responses to HypoxiaCompletedNCT02629406
- The Effect of Viscous Fiber on Glycemic Control in Individuals With DiabetesCompletedNCT02629263
- Diabeloop WP6.2 : Crossover Evaluation of Glycemic ControlCompletedNCT02627911Phase 2
- A Comparative Trial Focusing on Injections With the Medical Device DV3316 Pen-injector Versus FlexPen®CompletedNCT02627287Phase 1
- Safety of Overestimation of a Meal Insulin Bolus in the Context of Dual-hormone Closed-loop OperationCompletedNCT02626936Phase 2
- A Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of Escalating Doses of SAR438544 in Comparison to Placebo and Glucagon in Healthy Subjects and Type 1 Diabetes Mellitus PatientsCompletedNCT02625636Phase 1
- A Study of a Novel Insulin Lispro Formulation in Participants With Type 1 Diabetes Mellitus Using Insulin PumpsWithdrawnNCT02623478Phase 1
- A Study of a New Type of Insulin in Participants With Type 1 Diabetes on Insulin Injection TherapyWithdrawnNCT02623452Phase 1
- Primary Intervention With Mucosal InsulinCompletedNCT02620553Phase 1/2
- Multiple Islet Peptide Administration in Type 1 Diabetes (MultiPepT1De)CompletedNCT02620332Phase 1
- Fr1da Insulin InterventionCompletedNCT02620072Phase 2
- The Impact of Mobile Technology on Clinical Outcomes in Children and Adolescents With Type 1 DiabetesWithdrawnNCT02619487Not applicable
- Liraglutide Effect on Beta-cell Function in C-peptide Positive Type 1 DiabetesCompletedNCT02617654Phase 2
- Evaluation of Automated Insulin Pump Settings Using the Advisor Pro (Previously Called) MD-Logic Pump Advisor-three Segments StudyTerminatedNCT02617160Not applicable
- A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0143-0406 A 0.6 mmol/L in Subjects With Type 1 DiabetesCompletedNCT02612844Phase 1
- Obesity and Metabolic Surgery in Patients With Type I DiabetesCompletedNCT02612493
- Incretin-based Therapy in Preclinical Type 1 Diabetes in AdultsStatus unknownNCT02611232Phase 2
- Junior KICkOFF: Diabetes Education for Children Under 11 YearsCompletedNCT02610738Not applicable
- Effects of Gluten Free Diet on Type 1 Diabetes Mellitus in ChildrenTerminatedNCT02605564Not applicable
- TEFA Family Prevention: Glutenfree Diet to Preserve Beta-cell FunctionStatus unknownNCT02605148Not applicable
- Reducing Risks and Improving Glucose Control During Extended Exercise in Youth With T1DM: The AP Ski CampCompletedNCT02604524Not applicable
- Assessment of the Safety of SAR342434 and Humalog® When Administered as Continuous Subcutaneous Insulin InfusionCompletedNCT02603510Phase 1
- Reimbursement Study of Continuous Glucose Monitoring in BelgiumCompletedNCT02601729
- Diabetes Care Transformation: Diabetes Data Registry and Intensive Remote MonitoringCompletedNCT02596204Not applicable
- The GlucoPred Investigation IITerminatedNCT02595580Not applicable
- Diabetes Islet Preservation Immune TreatmentWithdrawnNCT02586831Phase 1/2
- The Effect of GLP-1 on Postprandial Glucagon Secretion Independent of The Gastric Emptying RateStatus unknownNCT02584582Phase 2/3
- Collagen Scaffolds Loaded With HUCMSCs for the Improvement of Erectile Function in Men With DiabetesWithdrawnNCT02579148Phase 1
- The Influence of Psychobiological Adversity to Children and Adolescents With Type 1 DiabetesCompletedNCT02575001
- Evolution of Effectiveness of Diabetes Medical Care in RussiaCompletedNCT02574195
- Investigating the Postprandial Glucose Metabolism After Treatment With Faster-acting Insulin Aspart in Subjects With Type 1 DiabetesCompletedNCT02568280Phase 1
- A Trial Investigating the Continuous Subcutaneous Insulin Infusion of a Liquid Formulation of BioChaperone Insulin Lispro in Comparison to Humalog®CompletedNCT02562313Phase 1
- Early Administration of Long-acting Insulin Treatment of Diabetic Ketoacidosis in Pediatric Type 1 DiabetesTerminatedNCT02548494Not applicable
- Pre-POINT-Early StudyCompletedNCT02547519Phase 2
- Glucose-stimulated Pancreatic Islet and Intestinal Blood Flow in Healthy Subjects and in Type 1 DiabetesCompletedNCT02547337
- Shared Medical Appointments to Improve Outcomes in Adolescents With Type 1 DiabetesCompletedNCT02547311Not applicable
- Comparison of Insulin's Injection Before or After the Meal in Type 1 Diabetic Patients Treated With Insulin PumpCompletedNCT02546401Phase 3
- Carbohydrate Estimation Supported by the GoCARB SystemCompletedNCT02546063Not applicable
- MoCa Test for the Early Detection of Mild Cognitive Impairment During Annual Assessment of Young Adults With Diabetes and in a Control Group Without DiabetesStatus unknownNCT02545062Not applicable
- Assessment of the Neurovascular Microcirculatory Response in Diabetes Type 1 PatientsCompletedNCT02538120Not applicable
- An Outpatient Study of Automated Blood Glucose Control With an Insulin-Only Bionic PancreasCompletedNCT02536950Not applicable
- Comparing Pharmacodynamic and Pharmacokinetic Properties of Insulin Degludec and Insulin Glargine 300 U/mL at Steady-state Conditions in Subjects With Type 1 Diabetes MellitusCompletedNCT02536859Phase 1
- Pharmacodynamics, Pharmacokinetics, and Safety of ASP1941 in Patients With Type 1 Diabetes MellitusCompletedNCT02529449Phase 2
- To Investigate the Efficacy and Safety of Individualized Doses of BioChaperone Insulin Lispro in Comparison to Humalog® U-100 in Patients With Type 1 Diabetes MellitusCompletedNCT02528396Phase 1
- First STEPS- Study of Type 1 in Early Childhood and Parenting SupportCompletedNCT02527525Not applicable
- An ACT Based Application for Young People With Type 1 DiabetesTerminatedNCT02526069Not applicable
- Home Testing of Day and Night Closed Loop With Pump Suspend FeatureCompletedNCT02523131Not applicable
- Validation of Algorithms for Basal Insulin Rate Reductions in Type 1 Diabetic Patients Practising Physical Activity in Real Life ConditionsCompletedNCT02521675Not applicable
- Aralast NP in Islet TransplantCompletedNCT02520076Phase 1/2
- How to be Safe With Alcoholic Drinks in DiabetesWithdrawnNCT02518022Not applicable
- Postprandial Blood Glucose Control With BioChaperone® Combo and Insulin Lispro (Humalog®) Mix 25 in People With Type 1 Diabetes MellitusCompletedNCT02514954Phase 1
- Comparison of an Artificial Pancreas Versus Threshold Low Glucose Suspend in Type 1 Diabetic ChildrenCompletedNCT02509429Phase 2
- BGAT (Blood Glucose Awareness Training) for Users Who Might Become PregnantCompletedNCT02508779Not applicable
- PK/PD Study of Gan & Lee's Insulin Glargine Injection in Comparison to Lantus in Type 1 DiabetesCompletedNCT02506647Phase 1
- Minimal Islet Transplant at Diabetes OnsetCompletedNCT02505893Phase 2
- Sleep and Type 1 DiabetesStatus unknownNCT02494375Not applicable
- The Effect of Type 1 Diabetes on Pan-Arterial Vascular Function and Insulin Sensitivity in HumansCompletedNCT02490124
- Closed-loop Control of Postprandial Glucose Levels in Children and Adults With Type 1 DiabetesWithdrawnNCT02490098Phase 2
- Closed-loop Control of Glucose Levels (Artificial Pancreas) for 5 Days in Adults With Type 1 DiabetesWithdrawnNCT02488616Phase 2
- GLUCOME USABILITY STUDYWithdrawnNCT02488278Not applicable
- PK and PD Within-Subject Variability of a Single Dose of Afrezza Inhaled Technosphere Insulin in Patients With Diabetes Mellitus Type 1 (T1DM)CompletedNCT02485327Phase 1
- Brain Ketone Metabolism in Type 1 DiabetesCompletedNCT02471040Phase 1
- Single Dose Clamp Study to Evaluate Concentration-time Profile and Metabolic Activity of 3 Dose Levels of Afrezza and 3 Dose Levels of Insulin Lispro in Patients With Type 1 Diabetes MellitusCompletedNCT02470637Phase 1
- Long Term CGM Treatment in Patients With Type 1 Diabetes Treated With Insulin InjectionsCompletedNCT02465411Not applicable